{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:08:11Z","timestamp":1789664891199,"version":"4.0.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81371414"],"award-info":[{"award-number":["81371414"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Major Scientific and Technological Special Project for Significant New Drug Development","award":["2013ZX09402203"],"award-info":[{"award-number":["2013ZX09402203"]}]},{"DOI":"10.13039\/501100010032","name":"Foundation of Shanghai Municipal Commission of Health and Family Planning","doi-asserted-by":"publisher","award":["2018JP001"],"award-info":[{"award-number":["2018JP001"]}],"id":[{"id":"10.13039\/501100010032","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.intimp.2019.02.035","type":"journal-article","created":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T22:35:55Z","timestamp":1551911755000},"page":"284-294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["The therapeutic potential of ginkgolide K in experimental autoimmune encephalomyelitis via peripheral immunomodulation"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9483-3027","authenticated-orcid":false,"given":"Wen-Bo","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7934-015X","authenticated-orcid":false,"given":"Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cun-Gen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Guo","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2019.02.035_bb0005","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bbadis.2010.07.007","article-title":"Inflammation, demyelination, and degeneration - recent insights from MS pathology","volume":"1812","author":"Stadelmann","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.intimp.2019.02.035_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04143.x","article-title":"T cells in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"162","author":"Fletcher","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2019.02.035_bb0015","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ana.24009","article-title":"Multiple sclerosis: prospects and promise","volume":"74","author":"Hauser","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.intimp.2019.02.035_bb0020","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S1474-4422(13)70192-3","article-title":"Emerging injectable therapies for multiple sclerosis","volume":"12","author":"Oh","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.intimp.2019.02.035_bb0025","unstructured":"Oz. TaSKapilioGLu, Recent advances in the treatment for multiple sclerosis; current new drugs specific for multiple sclerosis., Noro Psikiyatr. Ars. 55 (2018) S15\u2013S20."},{"issue":"9","key":"10.1016\/j.intimp.2019.02.035_bb0030","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00018-003-3080-1","article-title":"Neuroprotective effects of Ginkgo biloba extract","volume":"60","author":"Ahlemeyer","year":"2003","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.intimp.2019.02.035_bb0035","doi-asserted-by":"crossref","first-page":"12197","DOI":"10.1073\/pnas.182425199","article-title":"Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761","volume":"99","author":"Luo","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2019.02.035_bb0040","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1211\/0022357991772817","article-title":"Therapeutic value of Ginkgo biloba in reducing symptoms of decline in mental function","volume":"51","author":"Curtis-Prior","year":"1999","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.intimp.2019.02.035_bb0045","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0140-6736(87)90066-3","article-title":"Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man","volume":"1","author":"Chung","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2019.02.035_bb0050","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000438945","article-title":"Ginkgolide B reduces the degradation of membrane phospholipids to prevent ischemia\/reperfusion myocardial injury in rats","volume":"96","author":"Pei","year":"2015","journal-title":"Pharmacology"},{"key":"10.1016\/j.intimp.2019.02.035_bb0055","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/cns.12577","article-title":"Ginkgolide B protects against ischemic stroke via modulating microglia polarization in mice","volume":"22","author":"Shu","year":"2016","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.intimp.2019.02.035_bb0060","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/aps.2015.124","article-title":"Ginkgolide B protects human umbilical vein endothelial cells against xenobiotic injuries via PXR activation","volume":"37","author":"Zhou","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2019.02.035_bb0065","doi-asserted-by":"crossref","DOI":"10.4238\/gmr.15027673","article-title":"Alleviation of spinal cord injury by Ginkgolide B via the inhibition of STAT1 expression","volume":"15","author":"Zheng","year":"2016","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.intimp.2019.02.035_bb0070","first-page":"3522","article-title":"Effect of ginkgolide B on brain metabolism and tissue oxygenation in severe haemorrhagic stroke","volume":"8","author":"Chi","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"4","key":"10.1016\/j.intimp.2019.02.035_bb0075","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1523\/JNEUROSCI.1171-15.2016","article-title":"Platelet-activating factor receptors mediate excitatory postsynaptic hippocampal injury in experimental autoimmune encephalomyelitis","volume":"36","author":"Bellizzi","year":"2016","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.intimp.2019.02.035_bb0080","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/jnnp.58.3.360","article-title":"Double blind placebo controlled multicentre study of ginkgolide B in treatment of acute exacerbations of multiple sclerosis","volume":"58","author":"Brochet","year":"1995","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.intimp.2019.02.035_bb0085","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1080\/14786410601130547","article-title":"Determination of the derivative from ginkgolide B","volume":"22","author":"Yuan","year":"2008","journal-title":"Nat. Prod. Res."},{"issue":"1","key":"10.1016\/j.intimp.2019.02.035_bb0090","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11418-011-0545-7","article-title":"Neuroprotective effect of ginkgolide K against acute ischemic stroke on middle cerebral ischemia occlusion in rats","volume":"66","author":"Ma","year":"2012","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.intimp.2019.02.035_bb0095","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ejphar.2018.06.012","article-title":"Ginkgolide K promotes angiogenesis in a middle cerebral artery occlusion mouse model via activating JAK2\/STAT3 pathway","volume":"833","author":"Chen","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2019.02.035_bb0100","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10565-017-9419-4","article-title":"Ginkgolide K promotes the clearance of A53T mutation alpha-synuclein in SH-SY5Y cells","volume":"34","author":"Yu","year":"2018","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.intimp.2019.02.035_bb0105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.neuro.2011.11.003","article-title":"Neuroprotective effect of ginkgolide K on glutamate-induced cytotoxicity in PC 12 cells via inhibition of ROS generation and Ca 2+ influx","volume":"33","author":"Ma","year":"2012","journal-title":"Neurotoxicology"},{"issue":"2","key":"10.1016\/j.intimp.2019.02.035_bb0110","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1248\/bpb.b13-00378","article-title":"Neuroprotective effect of Ginkgolide K against H2O2-induced PC12 cell cytotoxicity by ameliorating mitochondrial dysfunction and oxidative stress","volume":"37","author":"Ma","year":"2014","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.intimp.2019.02.035_bb0115","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/bph.13516","article-title":"Ginkgolide K protects the heart against endoplasmic reticulum stress injury by activating the inositol-requiring enzyme 1alpha\/X box-binding protein-1 pathway","volume":"173","author":"Wang","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2019.02.035_bb0120","doi-asserted-by":"crossref","first-page":"575","DOI":"10.15171\/apb.2018.066","article-title":"A review of herbal therapy in multiple sclerosis","volume":"8","author":"Mojaverrostami","year":"2018","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.intimp.2019.02.035_bb0125","doi-asserted-by":"crossref","first-page":"44682","DOI":"10.18632\/oncotarget.17967","article-title":"Ginkgolide K attenuates neuronal injury after ischemic stroke by inhibiting mitochondrial fission and GSK-3β-dependent increases in mitochondrial membrane permeability","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2019.02.035_bb0130","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/glia.22930","article-title":"Sequential activation of microglia and astrocyte cytokine expression precedes increased Iba-1 or GFAP immunoreactivity following systemic immune challenge","volume":"64","author":"Norden","year":"2016","journal-title":"Glia"},{"key":"10.1016\/j.intimp.2019.02.035_bb0135","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.acthis.2013.04.007","article-title":"Activation profile of dorsal root ganglia Iba-1 (+) macrophages varies with the type of lesion in rats","volume":"115","author":"Ton","year":"2013","journal-title":"Acta Histochem."},{"key":"10.1016\/j.intimp.2019.02.035_bb0140","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2019.02.035_bb0145","doi-asserted-by":"crossref","unstructured":"S. Hori, T. Nomura, S. Sakaguchi, Control of regulatory T cell development by the transcription factor Foxp3, Science (80-.). 299 (2003) 1057\u20131061.","DOI":"10.1126\/science.1079490"},{"key":"10.1016\/j.intimp.2019.02.035_bb0150","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cytogfr.2010.10.006","article-title":"Signal transduction pathways and transcriptional regulation in Th17 cell differentiation","volume":"21","author":"Hirahara","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.intimp.2019.02.035_bb0155","doi-asserted-by":"crossref","first-page":"10190","DOI":"10.1073\/pnas.1703100114","article-title":"Treg-specific IL-27Ralpha deletion uncovers a key role for IL-27 in Treg function to control autoimmunity","volume":"114","author":"Do","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2019.02.035_bb0160","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2019.02.035_bb0165","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1182\/blood-2007-03-079947","article-title":"Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis","volume":"111","author":"Ephrem","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2019.02.035_bb0170","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1093\/brain\/awv256","article-title":"Multiple sclerosis associated genetic variants of CD226 impair regulatory T cell function","volume":"138","author":"Piedavent-Salomon","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.intimp.2019.02.035_bb0175","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.immuni.2011.01.020","article-title":"Th17 cells express interleukin-10 receptor and are controlled by Foxp3(\u2212) and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner","volume":"34","author":"Huber","year":"2011","journal-title":"Immunity."},{"key":"10.1016\/j.intimp.2019.02.035_bb0180","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1164\/rccm.201507-1499OC","article-title":"IFN-gamma-producing T-helper 17.1 cells are increased in sarcoidosis and are more prevalent than T-helper type 1 cells","volume":"193","author":"Ramstein","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2019.02.035_bb0185","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1126\/science.1172638","article-title":"Halofuginone inhibits TH17 cell differentiation by activating the amino acid starvation response","volume":"324","author":"Sundrud","year":"2009","journal-title":"Science (80-.)"},{"key":"10.1016\/j.intimp.2019.02.035_bb0190","doi-asserted-by":"crossref","first-page":"651503","DOI":"10.1155\/2014\/651503","article-title":"Th17 cells in autoimmune and infectious diseases","volume":"2014","author":"Zambrano-Zaragoza","year":"2014","journal-title":"Int J Inflam."},{"key":"10.1016\/j.intimp.2019.02.035_bb0195","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.autrev.2013.12.004","article-title":"Th17 and regulatory T cell balance in autoimmune and inflammatory diseases","volume":"13","author":"Noack","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2019.02.035_bb0200","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3389\/fimmu.2014.00554","article-title":"Myeloid colony-stimulating factors as regulators of macrophage polarization","volume":"5","author":"Hamilton","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2019.02.035_bb0205","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2019.02.035_bb0210","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.4049\/jimmunol.181.6.3733","article-title":"Macrophage polarization in bacterial infections","volume":"181","author":"Benoit","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2019.02.035_bb0215","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/imm.12571","article-title":"Interleukin-17A neutralization alleviated ocular neovascularization by promoting M2 and mitigating M1 macrophage polarization","volume":"147","author":"Zhu","year":"2016","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2019.02.035_bb0220","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1158\/1078-0432.CCR-13-0042","article-title":"IL-17-mediated M1\/M2 macrophage alteration contributes to pathogenesis of bisphosphonate-related osteonecrosis of the jaws","volume":"19","author":"Zhang","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2019.02.035_bb0225","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00395-017-0622-5","article-title":"IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation","volume":"112","author":"Jung","year":"2017","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.intimp.2019.02.035_bb0230","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.immunol.021908.132532","article-title":"Alternative activation of macrophages: an immunologic functional perspective","volume":"27","author":"Martinez","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2019.02.035_bb0235","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1084\/jem.192.7.1075","article-title":"Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2","volume":"192","author":"Izikson","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2019.02.035_bb0240","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1044-5323(02)00125-2","article-title":"The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE)","volume":"15","author":"Mahad","year":"2003","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.intimp.2019.02.035_bb0245","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0952-7915(94)90006-X","article-title":"Chemokines, leukocyte trafficking, and inflammation","volume":"6","author":"Schall","year":"1994","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.intimp.2019.02.035_bb0250","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jneuroim.2005.01.020","article-title":"CCL2 and CCL5 mediate leukocyte adhesion in experimental autoimmune encephalomyelitis--an intravital microscopy study","volume":"162","author":"dos Santos","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.intimp.2019.02.035_bb0255","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0165-5728(98)00002-2","article-title":"MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study","volume":"86","author":"McManus","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.intimp.2019.02.035_bb0260","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-5728(97)00208-7","article-title":"Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions","volume":"84","author":"Simpson","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.intimp.2019.02.035_bb0265","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4049\/jimmunol.160.2.550","article-title":"T helper 1 and T helper 2 cells respond differentially to chemokines","volume":"160","author":"Siveke","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2019.02.035_bb0270","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/jaut.2002.0591","article-title":"Crucial role of CCL3\/MIP-1alpha in the recurrence of autoimmune anterior uveitis induced with myelin basic protein in Lewis rats","volume":"18","author":"Manczak","year":"2002","journal-title":"J. Autoimmun."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919300414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919300414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T05:53:55Z","timestamp":1694670835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576919300414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":54,"alternative-id":["S1567576919300414"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.02.035","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The therapeutic potential of ginkgolide K in experimental autoimmune encephalomyelitis via peripheral immunomodulation","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.02.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}